New Talcum Powder Lawsuit Claims Early Diagnosis
Pennsylvania woman's baby powder cancer lawsuit claims she was just 24 when diagnosed with ovarian cancer, and believes it could have been prevented with better warnings issued by Johnson & Johnson concerning their talcum powder products.
Sunday, September 4, 2016 - A woman who claims she contracted ovarian cancer at the age of 24 has filed a Johnson & Johnson's baby powder lawsuit against the health care company claiming the company did not do enough to warn her of the carcinogenic properties of their popular cosmetic. More than 1,200 talcum powder lawsuits have been filed around the country, though most do not include a plaintiff who claims she first contracted ovarian cancer in her 20s. The bones of the claim however employ the same arguments and evidence as most of the hundreds of baby powder lawsuits around the country, and looks to recover damages from Johnson & Johnson for their failure to inform Handy of the cancer risk with their product.
Handy claims that she had used talcum powder products for genital hygiene support for most of her life before being diagnosed with ovarian cancer in 2005, when she was only 24. At no time prior had she been warned by Johnson & Johnson that dozens of studies existed linking prolonged use of talcum powder to ovarian cancer, and Hardy claims that the company was negligent and violated consumer protection laws by failing to do so. Like women all over the country who believe their ovarian cancer is linked to Johnson & Johnson's failure to alert them to the dangers of talcum powder, Handy claims that she would have likely used a different substance to support genital hygiene if she had been aware of the cancerous links associated with talcum powder.
Most women who have brought talcum powder lawsuits against Johnson & Johnson contracted the disease after they turned 40. This claim brought by Hardy is drastically different from those, and may open up other women who have contracted ovarian cancer early in their lives to review their talcum powder use and consider its role in their diagnosis.
Handy's talcum powder cancer attorney referenced more than 20 medical studies that found a correlation between talcum powder and an increased risk for ovarian cancer. Most of the claims filed against Johnson & Johnson have included these research studies as evidence that talcum powder has for decades been linked to ovarian cancer. Johnson & Johnson has maintained that they have studies of their own that refute the data included in the studies presented by the plaintiffs' baby powder attorneys, but they do not have the sheer volume of research that has been compiled against them.
Talcum powder cancer lawsuits filed in federal courts nationwide may soon find a new home, as a motion to transfer the litigation into an MDL was filed on July 15. The Judicial Panel on Multidistrict Litigation will hear arguments for and against consolidation at their next hearing session on September 29 in Washington D.C. In addition to whether the litigation will be transferred into an MDL, talcum powder ovarian cancer lawyers will also be pushing to have the lawsuits centralized in the U.S district court of their choice. The original motion to transfer named the Southern District of Illinois as their preferred location for centralization, though Oklahoma, Georgia, and New Jersey have all been mentioned in responses to the motion to transfer.
OnderLaw, LLC -